Virtus ETF Advisers LLC Vanda Pharmaceuticals Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$4.28 - $6.57 $26,857 - $41,226	-6,275 Reduced 11.45%	48,530 $209,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $72,363 - $85,241	12,265 Added 28.83%	54,805 $361,000
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $4,641 - $6,000	751 Added 1.8%	42,540 $288,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $115,793 - $184,730	16,855 Added 67.6%	41,789 $308,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $3,445 - $4,292	365 Added 1.49%	24,934 $246,000
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $11,488 - $14,610	1,234 Added 5.29%	24,569 $268,000
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $5,617 - $7,568	-358 Reduced 1.51%	23,335 $366,000
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $33,416 - $46,304	-2,177 Reduced 8.42%	23,693 $406,000
Q2 2021 Aug 10, 2021	SELL	$15.71 - $21.51 $346,311 - $474,166	-22,044 Reduced 46.01%	25,870 $556,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $17,607 - $26,607	1,312 Added 2.82%	47,914 $720,000
Q4 2020 Feb 12, 2021	SELL	$9.77 - $13.81 $79,869 - $112,896	-8,175 Reduced 14.92%	46,602 $612,000
Q3 2020 Nov 13, 2020	BUY	$9.32 - $12.02 $43,002 - $55,460	4,614 Added 9.2%	54,777 $529,000
Q2 2020 Aug 05, 2020	BUY	$9.66 - $12.02 $144,851 - $180,239	14,995 Added 42.64%	50,163 $574,000
Q1 2020 May 14, 2020	SELL	$7.5 - $16.8 $22,260 - $49,862	-2,968 Reduced 7.78%	35,168 $364,000
Q4 2019 Feb 13, 2020	SELL	$12.38 - $17.47 $115,554 - $163,064	-9,334 Reduced 19.66%	38,136 $626,000
Q3 2019 Nov 12, 2019	SELL	$12.27 - $15.79 $97,840 - $125,909	-7,974 Reduced 14.38%	47,470 $630,000
Q2 2019 Aug 13, 2019	BUY	$13.37 - $18.85 $741,286 - $1.05 Million	55,444 New	55,444 $781,000
Q1 2019 May 14, 2019	SELL	$17.59 - $31.05 $398,606 - $703,624	-22,661 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$18.97 - $31.47 $381,600 - $633,050	-20,116 Reduced 47.03%	22,661 $592,000
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $52,596 - $66,286	2,882 Added 7.22%	42,777 $982,000
Q2 2018 Aug 10, 2018	SELL	$13.95 - $19.15 $336,822 - $462,376	-24,145 Reduced 37.7%	39,895 $760,000
Q1 2018 May 14, 2018	SELL	$14.05 - $20.2 $53,010 - $76,214	-3,773 Reduced 5.56%	64,040 $1.08 Million
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $88,922 - $125,252	-6,920 Reduced 9.26%	67,813 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	74,733	74,733 $1.22 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$39.5 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$19.5 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$17.6 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $274M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account